Filter your results
- 2
- 1
- 3
- 3
- 2
- 1
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Sex differences in circulating proteins in heart failure with preserved ejection fractionBiology of Sex Differences, 2020, 11 (1), pp.47. ⟨10.1186/s13293-020-00322-7⟩
Journal articles
hal-02928742v1
|
||
|
Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure)Biomarkers, 2020, 25 (2), pp.201-211. ⟨10.1080/1354750X.2020.1727015⟩
Journal articles
hal-02732968v1
|
||
|
Efficacy and safety of pharmacological treatments for patent ductus arteriosus closure: A systematic review and network meta-analysis of clinical trials and observational studiesPharmacological Research, 2019, 148, pp.104418. ⟨10.1016/j.phrs.2019.104418⟩
Journal articles
hal-02872346v1
|